| __timestamp | MannKind Corporation | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79383000 | 44820000 |
| Thursday, January 1, 2015 | 108402000 | 82080000 |
| Friday, January 1, 2016 | 46928000 | 97130000 |
| Sunday, January 1, 2017 | 74959000 | 121271000 |
| Monday, January 1, 2018 | 79716000 | 153548000 |
| Tuesday, January 1, 2019 | 74669000 | 202541000 |
| Wednesday, January 1, 2020 | 59040000 | 245164000 |
| Friday, January 1, 2021 | 77417000 | 285773000 |
| Saturday, January 1, 2022 | 91473000 | 325998000 |
| Sunday, January 1, 2023 | 94314000 | 332540000 |
Cracking the code
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, PTC Therapeutics, Inc. and MannKind Corporation have taken different paths in optimizing these costs. From 2014 to 2023, MannKind's SG&A expenses fluctuated, peaking in 2015 and 2023, with a notable dip in 2016. In contrast, PTC Therapeutics saw a steady increase, with expenses rising by over 640% from 2014 to 2023. This trend suggests PTC's aggressive expansion strategy, while MannKind's more variable pattern may reflect strategic adjustments. As investors and analysts look for cost efficiency, understanding these trends provides valuable insights into each company's operational focus and financial strategy.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MannKind Corporation
Comparing SG&A Expenses: AstraZeneca PLC vs PTC Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Zoetis Inc. and PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or PTC Therapeutics, Inc.
Breaking Down SG&A Expenses: Viatris Inc. vs PTC Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Viatris Inc. and MannKind Corporation
Dr. Reddy's Laboratories Limited and MannKind Corporation: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and PTC Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Comparing SG&A Expenses: PTC Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Breaking Down SG&A Expenses: PTC Therapeutics, Inc. vs MiMedx Group, Inc.
MannKind Corporation and Novavax, Inc.: SG&A Spending Patterns Compared